EP4 receptor agonist L-902688 augments cytotoxic activities of ibrutinib, idelalisib, and venetoclax against chronic lymphocytic leukemia cells
| Autor: | Nabergoj, Sanja, Markovič, Tijana, Avsec, Damjan, Gobec, Martina, Podgornik, Helena, Jakopin, Žiga, Mlinarič-Raščan, Irena |
|---|---|
| Zdroj: | In Biochemical Pharmacology January 2021 183 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect